Safety Study of Albuterol Spiromax® in Subjects With Asthma

- Asthma
- Completed

Study Title: Safety Study of Albuterol Spiromaxֲ® in Subjects With Asthma

Teva Identifier: ABS-AS-307

ClinicalTrials.gov Identifier: NCT01698320

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Placebo MDPI | Drug: Albuterol MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: 10/01/2012 - 12/01/2013

Phase: Phase 3

Study Type

Interventional